Legal requirements for the preclinical toxicological evaluation of biomaterials

Clinical Materials - Tập 10 - Trang 51-57 - 1992
J. Leuschrier1
1Institut für Medizinische Chemie, Medizinische Hochschule Hannover, Postfach 610180, 3000 Hannover 61, Germany

Tài liệu tham khảo

Bundesgesetzblatt, 1976 Produkthaftungsgesetz, 1990 1989, Bundesgesundheitsblatt, 32, 108 Commission of the European Communities, 1990, The active implantable medical device directive, Official Journal of the European Communities, L 189 Commission of the European Communities, 1990 US Department of Health and Human Services Public Health Service, 1985 US Department of Health and Human Services Public Health Service, 1986 US Department of Health and Human Services Public Health Service, 1987 US Department of Health and Human Services Public Health Service, 1987 Autian, 1973, Toxicogenic potentials of biomaterials and methods for evaluating toxicity, Med. Instrum., 7, 125 US Department of Health and Human Services, 1987 Autian, 1980, Plastics Franck, 1987 Commission of the European Communities, 1983, Council Recommendation of 26 October 1983 Concerning Tests Relating to the Placing on the Market of Proprietary Medicinal Products (83/571/EEC), Official J. Europ. Commun., L 332, 11 World Health Organisation, 1969, Principles for the Testing and Evaluation of Drugs and Carcinogenicity, WHO Techn. Rep. Ser. 426 American Society for Testing and 'Materials (ASTM), Philadelphia, Pennsylvania, USA. Biologische Prüfungen von Dentalwerkstofffen, DIN V 13930, Beuth Verlag GmbH, Berlin, 1987.